These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1949033)

  • 41. Differential stability of drug-metabolizing enzyme activities in primary rat hepatocytes, cultured in the absence or presence of dexamethasone.
    McMillan JM; Shaddock JG; Casciano DA; Arlotto MP; Leakey JE
    Mutat Res; 1991 Jul; 249(1):81-92. PubMed ID: 2067545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of UDP-glucuronosyltransferase activities in Gunn, heterozygous, and Wistar rat livers by pregnenolone-16 alpha-carbonitrile.
    Watkins JB; Klaassen CD
    Drug Metab Dispos; 1982; 10(6):590-4. PubMed ID: 6130905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of hepatic glutathione S-transferase and UDP-glucuronosyltransferase activities by ketamine in rats.
    Chan WH; Su HC; Hung MH; Sun WZ; Fan SZ; Hsiao PN; Ueng TH
    Acta Anaesthesiol Taiwan; 2008 Mar; 46(1):2-7. PubMed ID: 18390394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimurium.
    Glatt HR; Robertson LW; Arand M; Rauch P; Schramm H; Setiabudi F; Pöchlauer P; Müller EP; Oesch F
    Arch Toxicol; 1986 Dec; 59(4):242-8. PubMed ID: 3548649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of strain and diet upon constitutive and chemically induced activities of several xenobiotic-metabolizing enzymes in rats.
    Stott WT; Kan HL; McFadden LG; Sparrow BR; Gollapudi BB
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):325-33. PubMed ID: 15135211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developmental alteration of hepatic UDP-glucuronosyltransferase and sulphotransferase towards androsterone and 4-nitrophenol in Wistar rats.
    Matsui M; Watanabe HK
    Biochem J; 1982 May; 204(2):441-7. PubMed ID: 6810881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells.
    Doostdar H; Grant MH; Melvin WT; Wolf CR; Burke MD
    Biochem Pharmacol; 1993 Aug; 46(4):629-35. PubMed ID: 8395842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of drug-metabolizing enzymes by the enantiomers of normephenytoin in the rat.
    James R; Küpfer A; Villeneuve JP; Branch RA
    Drug Metab Dispos; 1981; 9(3):297-302. PubMed ID: 6113944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Octachlorostyrene induces cytochrome P450, UDP-glucuronosyltransferase, and sulfotransferase via the aryl hydrocarbon receptor and constitutive androstane receptor.
    Yanagiba Y; Ito Y; Kamijima M; Gonzalez FJ; Nakajima T
    Toxicol Sci; 2009 Sep; 111(1):19-26. PubMed ID: 19525444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential time-course of induction of rat liver gamma-glutamyltransferase and drug-metabolizing enzymes in the endoplasmic reticulum, Golgi and plasma membranes after a single phenobarbital injection. Evaluation of protein variations by two-dimensional electrophoresis.
    Antoine B; Rahimi-Pour A; Siest G; Magdalou J; Galteau MM
    Cell Biochem Funct; 1987 Jul; 5(3):217-31. PubMed ID: 2886233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of hepatic xenobiotic metabolizing enzymes in female Fischer-344 rats following repeated inhalation exposure to decamethylcyclopentasiloxane (D5).
    McKim JM; Choudhuri S; Wilga PC; Madan A; Burns-Naas LA; Gallavan RH; Mast RW; Naas DJ; Parkinson A; Meeks RG
    Toxicol Sci; 1999 Jul; 50(1):10-9. PubMed ID: 10445748
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal detergent activation of rat liver microsomal UDP-glucuronosyl transferases toward morphine and 1-naphthol: contribution to induction and latency studies.
    Lett E; Kriszt W; de Sandro V; Ducrotoy G; Richert L
    Biochem Pharmacol; 1992 Apr; 43(7):1649-53. PubMed ID: 1567486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat.
    Turesky RJ; Markovic J; Bracco-Hammer I; Fay LB
    Carcinogenesis; 1991 Oct; 12(10):1847-55. PubMed ID: 1934266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction and inhibition of cytochrome P450 and drug-metabolizing enzymes by climbazole.
    Kobayashi Y; Suzuki M; Ohshiro N; Sunagawa T; Sasaki T; Oguro T; Tokuyama S; Yamamoto T; Yoshida T
    Biol Pharm Bull; 2002 Jan; 25(1):53-7. PubMed ID: 11824557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver.
    Oesch F; Arand M; Benedetti MS; Castelli MG; Dostert P
    J Antimicrob Chemother; 1996 Jun; 37(6):1111-9. PubMed ID: 8836814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
    Manning BW; Franklin MR; Galinsky RE
    Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
    Dirven HA; van den Broek PH; Peters JG; Noordhoek J; Jongeneelen FJ
    Biochem Pharmacol; 1992 Jun; 43(12):2621-9. PubMed ID: 1632818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug metabolism in hepatocyte sandwich cultures of rats and humans.
    Kern A; Bader A; Pichlmayr R; Sewing KF
    Biochem Pharmacol; 1997 Oct; 54(7):761-72. PubMed ID: 9353130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
    Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
    Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats.
    Maliakal PP; Coville PF; Wanwimolruk S
    J Pharm Pharmacol; 2001 Apr; 53(4):569-77. PubMed ID: 11341376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.